AstraZeneca shares tumble after reports China unit is linked to insurance fraud

By The Guardian | Nov 5, 2024 at 01:22 PM EST

AstraZeneca's weight loss pill received underwhelming reviews, causing its share price to drop by 8%. Additionally, the company's China unit faces an insurance fraud case, with dozens of executives under investigation. AstraZeneca is cooperating with Chinese authorities amidst these challenges.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.